Efficacy of Gefitinib for Young Patients with Unknown EGFR Gene Mutation 
in Advanced Lung Adenocarcinoma

Efficacy of Gefitinib for Young Patients with Unknown EGFR Gene Mutation 
in Advanced Lung Adenocarcinoma

Background and objective Lung cancer in young patients (less or equal to 45 years) is relatively rare. We explored the efficacy and survival of Gefitinib for young patients with unknown epidermal growth factor receptor (EGFR) gene mutation of advanced lung adenocarcinoma. Methods The clinical data o...

Full description

Bibliographic Details
Main Authors: Yutao LIU, Yuankai SHI, Xingsheng HU, Xuezhi HAO, Junling LI, Ziping WANG, Yan WANG, Hongyu WANG, Xiangru ZHANG, Yan SUN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Adenocarcinoma
Gefitinib
Young patient
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.05.06

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2014.05.06

Similar Items